Cargando…
Diffuse reduction of cerebral grey matter volumes in Erdheim-Chester disease
BACKGROUND: Erdheim-Chester disease (ECD) is a rare non-Langerhans histiocytosis characterized by systemic inflammation and granulomatous infiltration of multiple organs including the central nervous system (CNS), bones, and retroperitoneum. CNS infiltration occurs in one third of patients, but cogn...
Autores principales: | Diamond, Eli L., Hatzoglou, Vaios, Patel, Sneha, Abdel-Wahab, Omar, Rampal, Raajit, Hyman, David M., Holodny, Andrei I., Raj, Ashish |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4971748/ https://www.ncbi.nlm.nih.gov/pubmed/27484739 http://dx.doi.org/10.1186/s13023-016-0490-3 |
Ejemplares similares
-
Cobimetinib‐induced “dropped head syndrome” and subsequent disease management in an Erdheim‐Chester patient
por: King, Amber C., et al.
Publicado: (2019) -
Erdheim-Chester Disease
por: Yamamoto, Shinya, et al.
Publicado: (2019) -
The Contribution of MicroRNAs to the Inflammatory and Neoplastic Characteristics of Erdheim–Chester Disease
por: Weissman, Ran, et al.
Publicado: (2020) -
Erdheim-Chester disease among neuroinflammatory syndromes: the case for precision medicine
por: de la Fuente, Macarena I., et al.
Publicado: (2020) -
(18)F-FDG PET/CT versus anatomic imaging for evaluating disease extent and clinical trial eligibility in Erdheim-Chester disease: results from 50 patients in a registry study
por: Kirchner, Julian, et al.
Publicado: (2020)